Analysis of SGLT2 Inhibitor Therapy and Other Potential Risk Factors for the Development of Bacteremia in Patients With Urosepsis

Background: Risk factors for the development of bacteremia in patients with urosepsis are not well-defined in the current literature. Objective: To assess potential risk factors, including receipt of SGLT2 inhibitor therapy (SGLT2-I), for the development of bacteremia in patients with urosepsis. Met...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Journal of pharmacy technology 2022-04, Vol.38 (2), p.67-74
Hauptverfasser:	Covington, Elizabeth W., Slaten, Kelly, Harnden, Adam
Format:	Artikel
Sprache:	eng
Schlagworte:	Research Reports
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!